ONCTERNAL THERAPEUTICS INC's ticker is ONCT and the CUSIP is 68236P107. A total of 81 filers reported holding ONCTERNAL THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $29,394 | -13.1% | 97,980 | -0.0% | 0.00% | – |
Q2 2023 | $33,806 | -35.1% | 97,987 | +47.6% | 0.00% | – |
Q1 2023 | $52,102 | -27.7% | 66,372 | -7.8% | 0.00% | – |
Q4 2022 | $72,021 | +16.2% | 72,021 | +3.4% | 0.00% | – |
Q3 2022 | $62,000 | -87.4% | 69,684 | -84.3% | 0.00% | – |
Q2 2022 | $493,000 | -29.8% | 444,652 | -11.9% | 0.00% | – |
Q1 2022 | $702,000 | -50.7% | 504,567 | -19.6% | 0.00% | – |
Q4 2021 | $1,424,000 | -35.3% | 627,328 | +18.8% | 0.00% | – |
Q3 2021 | $2,201,000 | +68.8% | 527,868 | +92.3% | 0.00% | – |
Q2 2021 | $1,304,000 | +234.4% | 274,481 | +486.6% | 0.00% | – |
Q1 2021 | $390,000 | +64.6% | 46,793 | -3.4% | 0.00% | – |
Q4 2020 | $237,000 | +415.2% | 48,430 | +80.4% | 0.00% | – |
Q3 2020 | $46,000 | -24.6% | 26,842 | +25.8% | 0.00% | – |
Q2 2020 | $61,000 | +90.6% | 21,342 | +97.0% | 0.00% | – |
Q1 2020 | $32,000 | -31.9% | 10,832 | -8.2% | 0.00% | – |
Q4 2019 | $47,000 | +4.4% | 11,800 | +30.9% | 0.00% | – |
Q3 2019 | $45,000 | -8.2% | 9,012 | +21.5% | 0.00% | – |
Q2 2019 | $49,000 | – | 7,419 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACT CAPITAL MANAGEMENT, LLC | 360,000 | $1,710,000 | 0.88% |
APIS CAPITAL ADVISORS, LLC | 120,000 | $570,000 | 0.49% |
Parkman Healthcare Partners LLC | 415,384 | $1,973,000 | 0.43% |
Altium Capital Management LP | 172,218 | $818,000 | 0.19% |
Vigilare Wealth Management | 52,535 | $250,000 | 0.15% |
BRIGHTON JONES LLC | 332,875 | $1,581,000 | 0.08% |
Ikarian Capital, LLC | 200,204 | $950,000 | 0.08% |
IPG Investment Advisors LLC | 31,106 | $147,754,000 | 0.04% |
DOWLING & YAHNKE LLC | 150,464 | $715,000 | 0.04% |
Jump Financial, LLC | 58,225 | $276,000 | 0.03% |